Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
New Vestibular CPT® Codes for 2027 Implementation
This content is an exclusive benefit for American Academy of Audiology members. If you’re a member, log in and you’ll get immediate access. Member Login…
Use of a Tablet-Based Mobile Classifier to Diagnose Vestibular Disorders
In a preprint article by Rye et al. (2026), the feasibility of utilizing a tablet-based screening questionnaire (“mobile classifier”) to diagnose vestibular disorders was studied….
Where Audiology Comes Together: Join Us for AAA 2027 in St. Louis
Every year, the AAA Annual Convention brings the audiology community together to learn, connect, and move the profession forward. From April 7–10, 2027, that tradition…



